Evidence map›Paper›PMID 34181217›Full record

ArticleDermatology and therapy2021

Correction to: Development and Content Validation of Pruritus and Symptoms Assessment for Atopic Dermatitis (PSAAD) in Adolescents and Adults with Moderate-to-Severe AD.

Rebecca Hall, Mark G Lebwohl, Andrew G Bushmakin, Eric L Simpson, Melinda J Gooderham, Andreas Wollenberg, Adam Gater, Jane R Wells, Joseph C Cappelleri, Ming-Ann Hsu and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Dermatology and therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Rebecca HallPatient-Centered Outcomes, Adelphi Values, Adelphi Mill, Bollington, Cheshire, UK. rebecca.hall@adelphivalues.com.ORCID http://orcid.org/0000-0001-9530-0505
Mark G LebwohlKimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Andrew G BushmakinPIH Statistics, Pfizer Inc., Groton, CT, USA.
Eric L SimpsonDepartment of Dermatology, Oregon Health and Science University, Portland, OR, USA.
Melinda J GooderhamSKiN Centre for Dermatology and Probity Medical Research, Peterborough, ON, Canada.
Andreas WollenbergDepartment of Dermatology and Allergy, Ludwig-Maximilians-Universität München, Munich, Germany.
Adam GaterPatient-Centered Outcomes, Adelphi Values, Adelphi Mill, Bollington, Cheshire, UK.
Jane R WellsPatient-Centered Outcomes, Adelphi Values, Adelphi Mill, Bollington, Cheshire, UK.
Joseph C CappelleriGlobal Biometrics and Data Management, Pfizer Inc., Groton, CT, USA.
Ming-Ann HsuPIH-Global Health and Value, Pfizer Inc., Groton, CT, USA.
Jocelyn PapacharalambousPfizer Inc., New York, NY, USA.
Elena PeevaR&D-Inflammation and Immunology, Pfizer Inc., Cambridge, MA, USA.
Anna M TallmanPfizer Inc., New York, NY, USA.
Weidong ZhangPfizer Inc., Cambridge, MA, USA.
Linda ChenPfizer Inc., New York, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34181217
PMCPMC8322250

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.